Impact of baseline corticosteroids on survival and steroid androgens in metastatic castration-resistant prostate cancer: Exploratory analysis from COU-AA-301 Academic Article uri icon

Overview

MeSH Major

  • Adrenal Cortex Hormones
  • Androstenes
  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasm Metastasis
  • Prednisone
  • Prostatic Neoplasms, Castration-Resistant

abstract

  • Baseline corticosteroids did not adversely affect abiraterone clinical benefit in metastatic castration-resistant prostate cancer. Their use was associated with patients having worse disease characteristics.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2014.06.042

PubMed ID

  • 25018037

Additional Document Info

start page

  • 866

end page

  • 73

volume

  • 67

number

  • 5